Fig. 3From: Can the apparent transverse relaxation rate (R2*) evaluate the efficacy of concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma? a preliminary experienceThe area under the ROC curve on R2*postT and ΔR2* for differentiating the therapeutic response to CCRT. ROC, receiver operating characteristic; CCRT, concurrent chemoradiotherapyBack to article page